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The downside of microtubule stability
S
talled microtubules might 
be responsible for some 
cases of the neurological 
disorder Charcot-Marie-Tooth 
(CMT) disease, Tanabe and Takei 
report. A mutant protein makes the 
microtubules too stable to perform 
their jobs, the researchers fi  nd.
The mutations behind CMT 
disease slow nerve impulses, re-
duce their strength, or both. One 
of these mutations leads to production of faulty dynamin 2, a protein 
that is crucial for endocytosis but also latches onto microtubules. Tanabe 
and Takei investigated how defective dynamin 2 hampers cells.
Normal microtubules are continually extending and shrinking. 
But microtubules from cells that made the faulty version of dynamin 2 
were abnormally stable, as measured by how many acetyl groups were 
attached to them. The researchers also found that blocking normal 
dynamin 2 with RNAi had the same effect as the mutation, confi  rming 
that one of dynamin 2’s functions is to promote microtubule turnover.
Removing dynamin 2 shattered the Golgi complex, Tanabe 
and Takei discovered. Dynamic microtubules help construct the 
Golgi complex in two ways: they capture the vesicles that combine 
to form a mature Golgi complex; and they provide a track along 
which these vesicles can travel to their rendezvous point near the 
nucleus. By breaking up the Golgi apparatus and then watching 
the fragments reunite, the researchers found that dynamin 2 was 
essential for the capture step, not for transportation. Dynamin 2 
also clings to microtubules of the mitotic spindle, and the team 
next wants to determine whether the protein regulates microtubule 
dynamics during the cell cycle.
Tanabe, K., and K. Takei. 2009. J. Cell Biol. doi:10.1083/jcb.200803153.
CD44’s nuclear road trip
L
ee et al. reveal how a char-
acteristic surface marker 
for cancer stem cells trig-
gers abnormal growth. The protein 
makes a dash for the nucleus, pick-
ing up a couple of accomplices, 
including the transcription activa-
tor STAT3, along the way.
The surface receptor CD44 is overexpressed in many tumor 
types, including stomach cancer. Responding to neighboring cells 
and the extracellular matrix, the protein helps control everything from 
differentiation to survival. At the membrane, CD44 promotes signaling 
through the integrin proteins by corralling lipid rafts. Other scientists 
had previously shown that a snippet of CD44 could turn on genes in the 
nucleus. But whether the full-length protein could get there and what 
functions it might perform once it arrived were uncertain.
Lee et al. found that after stimulation, CD44 molecules 
evacuate the membrane of stomach cancer cells via the endocytic 
pathway. The proteins wend through the cytosol and eventually slip 
into the nucleus through a nuclear pore. A mutant protein lacking 
the nuclear localization sequence was locked out of the nucleus. But 
CD44 doesn’t travel solo. On the way, it links up with STAT3 and 
another protein, p300. This meeting leads to STAT3’s acetylation 
and activation. Once the combo reaches the nucleus, it latches 
onto the promoter for the cyclin D1 gene, which nudges the cell 
from the G1 phase into the S phase, thus speeding cell division. 
Other cancer-related surface receptors such as EGFR migrate into 
the nucleus. But they exert their effects through their enzymatic 
activity, whereas CD44 serves as a scaffold for other proteins, the 
researchers say. Still a mystery is how CD44’s mobility relates to its 
role as a cancer stem cell marker.
Lee, J.-L., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200812060.
STAT3 (red) waits in the cytosol 
(left) but hitches a ride into the 
nucleus with CD44 (right).
How a membrane gets the bends
T
wo dueling proteins help 
crimp the inner mito-
chondrial membrane 
into its familiar, accordion-like 
shape, Rabl et al. show.
The inner membrane 
of a mitochondrion is split 
into two parts. The peripheral 
portion, the inner boundary 
membrane, rests against a 
second membrane that encapsulates the organelle. Meanwhile 
the innermost portion, or cristae membrane, doubles back on 
itself again and again to form pleats, or cristae. A section of 
cristae membrane bends at two points—its tip and its base, 
where it connects to the inner boundary membrane. The tube-like 
structure that links the cristae and inner boundary membranes at 
this point is called a crista junction. How these connections form 
is a mystery.
To fi nd out, Rabl et al. screened slow-growing yeast mutants, 
which often harbor malformed mitochondria. They pinpointed a 
strain that sported a faulty version of a protein they dubbed Fcj1. The 
protein embeds in the inner membrane and is particularly common 
at crista junctions, making it the fi  rst component of the junctions to 
be identifi  ed. Cranking up Fcj1’s expression boosted the number 
of these junctions. When the team deleted Fcj1, by contrast, crista 
junctions vanished, and the cristae membrane distorted into parallel 
stacks of vesicles rather than a series of folds.
The researchers found that the ATP-making protein complex 
F  1 F O   shows the opposite distribution to Fcj1—it amasses at cristae 
tips but is scarce at crista junctions. The two proteins appear to 
have an opposing function as well. Fcj1 prevents dimers of the 
synthase from zipping together. The researchers hypothesize that 
the curvature of the membrane at any point depends on the balance 
of Fcj1 and the ATP synthase. F  1 F O bends the membrane in one 
direction, whereas Fcj1 bends it the opposite way.
Rabl, R., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200811099.
In a cell lacking dynamin 2, 
the pre-Golgi vesicles (green 
spheres) remain dispersed.
Crista junctions are prevalent in 
a normal mitochondrion (left) but 
disappear when Fcj1 is absent (right).